Related Experiment Video

Updated: May 4, 2026

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis
08:34

Mechanism of Regulation of Adipocyte Numbers in Adult Organisms Through Differentiation and Apoptosis Homeostasis

Published on: June 3, 2016

17.2K

Suppression of PPARγ through MKRN1-mediated ubiquitination and degradation prevents adipocyte differentiation

J-H Kim1, K W Park2, E-W Lee1

  • 1Department of Biochemistry, College of Life Science and Biotechnology, Yonsei University, Seoul 120-749, Republic of Korea.

Cell Death and Differentiation
|December 17, 2013
PubMed

Insights

MKRN1 acts as an E3 ligase, targeting PPARγ for degradation and inhibiting fat cell differentiation. This discovery reveals MKRN1 as a potential therapeutic target for obesity and metabolic diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Cell Biology

Background:

  • Peroxisome proliferator-activated receptor gamma (PPARγ) is a key regulator of adipogenesis, implicated in obesity and metabolic disorders.
  • Understanding the regulation of PPARγ protein stability is crucial for developing therapeutic strategies against related diseases.

Purpose of the Study:

  • To identify and characterize the E3 ligase responsible for PPARγ ubiquitination and degradation.
  • To elucidate the role of MKRN1 in regulating adipocyte differentiation and PPARγ protein levels.

Main Methods:

  • Ubiquitination assays to detect PPARγ modification by MKRN1.
  • Cellular experiments involving stable MKRN1 overexpression and depletion in preadipocyte cell lines (3T3-L1, C3H10T1/2).
  • Analysis of adipocyte differentiation markers and PPARγ protein levels in MKRN1 knockout mouse embryonic fibroblasts (MEFs).

Main Results:

  • MKRN1 was identified as an E3 ligase that ubiquitinates PPARγ at lysine residues 184 and 185.
  • Overexpression of MKRN1 led to decreased PPARγ levels and suppressed adipogenesis, while MKRN1 depletion enhanced differentiation.
  • MKRN1 knockout MEFs exhibited increased adipocyte differentiation capacity with elevated PPARγ and adipogenic markers.

Conclusions:

  • MKRN1 targets PPARγ for proteasomal degradation via ubiquitination, acting as a negative regulator of adipogenesis.
  • MKRN1 represents a novel therapeutic target for diseases associated with dysregulated PPARγ activity, such as obesity and metabolic syndrome.

More Related Videos

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells07:22

Isolation and Differentiation of Stromal Vascular Cells to Beige/Brite Cells

Published on: March 28, 2013

38.4K
Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator06:08

Author Spotlight: Semi-Automated Isolation of the Stromal Vascular Fraction from Murine White Adipose Tissue Using a Tissue Dissociator

Published on: May 19, 2023

2.8K

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.0K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.1K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
5.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
GPCR Desensitization01:12

GPCR Desensitization

G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
6.1K